The latest thoracic oncology news
Crizotinib was the first drug licensed to treat ALK-positive non-small cell lung cancer (ALK NSCLC).…
In a recent study, adults who were the most fit had the lowest risk of…
A group of respiratory medicine and public health experts are calling for lung cancer in…
Genomic differences related to the immune system may play a key role in the early…
University of Texas at Dallas scientists have demonstrated that the growth rate of the majority…
Two studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of…
Findings from a new study show that the compound responsible for chilli peppers’ heat could…
The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumour activity with durable responses in patients…
Early specialist palliative care treatment does not improve the quality of life for patients diagnosed…
Prophylactic cranial irradiation (PCI), a technique used to prevent the clinical development of brain metastases,…